The Metabolome of Carbapenem-Resistant Klebsiella pneumoniae Infection in Plasma

Wen, Zhongwei; Liu, Mei; Rui, Dong; Liao, Xiaoxiao; Su, Rui; Tang, Zhenming; Wen, Zhineng; Ling, Zhougui

doi:https://doi.org/10.1155/2021/7155772

Disease Markers

On this page

Abstract Introduction Methods Results Discussion Limitations Data Availability Conflicts of Interest Authors’ Contributions Supplementary Materials References Copyright Related Articles

Special Issue

Body Fluid Biomarkers in Chronic Diseases

View this Special Issue

Research Article | Open Access

Volume 2021 | Article ID 7155772 | https://doi.org/10.1155/2021/7155772

The Metabolome of Carbapenem-Resistant Klebsiella pneumoniae Infection in Plasma

Zhongwei Wen,¹Mei Liu,¹Dong Rui,¹Xiaoxiao Liao,¹Rui Su,¹Zhenming Tang,¹Zhineng Wen,¹and Zhougui Ling¹

Academic Editor: Wen-Qing Shi

Received17 Aug 2021

Revised13 Sept 2021

Accepted12 Oct 2021

Published22 Oct 2021

Abstract

Aim. Carbapenem-resistant Klebsiella pneumoniae- (CR-Kp-) mediated infections represent a challenge for clinical practitioners due to their expanding prevalence in hospital environments and antibiotic resistance. However, few studies have shown metabolic changes of carbapenem-resistant Klebsiella pneumoniae and CR-Kp-negative patients, and relevant studies are urgently needed. Methods. In this study, we comprehensively profile the metabolites of 20 CR-Kp-positive and 18 CR-Kp-negative patients in plasma by using 2D gas chromatography–time-of-flight mass spectrometry (GC×GC-TOFMS). Results. We identified 58 metabolites that were carbapenem-resistant Klebsiella pneumoniae-associated. N-Acetyl glucosamine, butanedioic acid, and myoinositol play a significant character in CR-Kp infection. Conclusions. Our study provides valuable data to serve as potential targets for developing therapies against CR-Kp infection.

1. Introduction

Klebsiella pneumoniae (K. pneumoniae), a Gram-negative bacterium, is an essential member of the Klebsiella genus of Enterobacterales. K. pneumoniae infections constitute a significant cause of morbidity and mortality globally. These infections generally start elsewhere, typically the lungs, genitourinary tract, or gastrointestinal tract [1, 2].

Carbapenem-resistant K. pneumoniae (CR-Kp) is a multidrug-resistant pathogen, which affects people worldwide, prevalent in low, middle, and upper-income countries [3]. The primary mechanism mediates resistance to carbapenems: CR-Kp can produce β-lactamases with the ability to hydrolyze cephalosporins and reduce membrane permeability in the cell wall [4, 5]. CR-Kp infections have provided enhanced mortality and many costs for health care systems. Moreover, the pathogen’s multidrug resistance to newly expanded antibiotics causes the therapy of K. pneumoniae infections much more challenging [6]. Hence, it is urgent to develop and increase our understanding of how host defenses limit CR-Kp diffusion and pathogenesis and produce innovative therapeutic procedures.

Metabolomics (or metabolome) is a rapidly developing method that is aimed at identifying and quantifying the fluctuations in the concentrations of metabolites in a biological sample, such as blood, urine, or saliva [7]. Metabolomics studies are routinely conducted using analytical instrumentation like liquid or gas chromatography-mass spectrometry (LC-MS and GC–MS, respectively) and nuclear magnetic resonance (NMR) to draw a metabolic atlas by detecting metabolites [8, 9, 10, 11]. And this method has been widely used in many studies of Klebsiella pneumonia in the past [12]. Nevertheless, there are few studies on the metabolome of CR-Kp-infected patients.

This study is aimed at providing the first comprehensive analysis of the metabolome of CR-Kp-infected patients. Through metabolome analysis of the plasma of infected patients, we can better understand the metabolic changes of CR-Kp infection and discover feasible targets for future treatment.

2. Methods

2.1. Clinical Samples

Blood samples were collected from 38 patients, which included 20 patients infected by carbapenem-resistant K. pneumoniae (CR-Kp) in the Fourth Affiliated Hospital of Guangxi Medical University from March 2016 to July 2020 (Table 1). Blood cultures were performed by automated systems (BacTAlert®, USA). K. pneumoniae isolate identity and antimicrobial susceptibility testing (AST) used the Vitek 2 System (bioMérieux, USA). Eighteen adult patients with blood cultures negative for CR-Kp were classified as the CR-Kp-negative group (Table 1). Informed written consent was obtained from each patient. Plasma samples were collected within 24 h after admission. Blood samples were centrifuged at for 15 minutes at 4°C for plasma collection and deposited at -80°C.

2.2. Metabolomics

GC×GC-TOFMS (LECO, USA) sample preparation, derivatization, and spectral acquisition were prepared according to published methods [13]. Briefly, 50 μL of plasma and 300 μL of mixed solvent (, Thermo Fisher, USA) were added into a 1.5 mL centrifuge tube and vortexed for 30 s. Leave the hybrid solution in the refrigerator at −20°C for 10 minutes. After centrifugation at 1000 RPM for ten minutes, transfer 300 μL of the supernatant to the vial and add 10 μL of 0.1 mg mL^-1 chlorobenzene (Thermo Fisher, USA), alanine (Sigma-Aldrich, USA), and 1 mg mL^-1 heptadecanoic acid. After the sample was freeze-dried, 80 μL of 15 mg mL⁻¹ pyridine (Sigma-Aldrich, USA) dissolved methoxamine and 50 μL BSTFA (1%TMCS, Sigma-Aldrich, USA) were added, respectively. The mixed sample was at 70°C for 60 minutes and then cooled down before injection.

2.3. Statistical Analysis

All results are shown as the . Statistical analysis was conducted using unpaired Student’s -tests for two groups and one-way analysis of variance (ANOVA) or two-way ANOVA for multiple groups. Missing values were imputed by MetImp 1.2 [14]. Feature selection and modeling were performed by Random forest, owing to its advantages in small sample sizes, complicated data structure, and high-dimensional feature space. Random forests were implemented using the “randomForest” R package. All analyses were performed using R software (version 4.0.2).

3. Results

3.1. Metabolic Profiling of Plasma

Principal component analysis (PCA) and partial least squares-discriminant analysis (PLS-DA) analytical procedures were implemented in this investigation to distinguish significantly changed metabolites induced by CR-Kp infection. Figure 1 shows that the CR-Kp-positive and CR-Kp-negative groups separate in the PCA and PLS-DS plots. This suggests that the significant metabolite variation between the two groups can be identified.

(a)

(b)

A total of 58 significantly changed metabolites () were detected (Supplementary Table 1). Carbohydrates, organic acids, fatty acids, and amino acids were significantly altered in the CR-Kp-positive group. Moreover, the volcano plot (Figure 2(a)) indicates differentially expressed metabolites ( and ). In detail, all selected meaningful metabolites are shown in the heat map (Figure 2(b)).

(a)

(b)

3.2. Key Metabolites Identified by Random Forest

Random forest (RF) was utilized on the dataset for the two comparative cases. The model was built based on 58 significantly changed metabolites. Figure 3(a) shows the separation between the CR-Kp-negative group and the positive group. RF yielded 98.37% classification accuracy with 100 trees (Figure 3(b)). The variable number dependence section evaluates whether and how much RF performance depends on the number of variables included. This section assesses its capability on an important variable (key metabolites) preference. Figure 3(c) displays the top 15 metabolites’ mean decrease accuracy, revealing how much the model loses by excluding each variable. The more the accuracy endures, the more influential the variable is for the successful classification. The variables are shown with descending importance. N-Acetyl glucosamine, butanedioic acid, and myoinositol are the most significant metabolites with the differential infected and control groups.

(a)

(b)

(c)

3.3. Key Metabolite’s Function Analysis

Differentially expressed metabolite correlation analysis was applied to analyze the consistency of metabolite trends (Supplementary Figure S1). The metabolite’s interrelation was assessed by Pearson correlation, and the results reveal significant metabolite-metabolite correlations. All differential metabolites were mapped to terms in the KEGG database and GO pathway to understand the functions of differential metabolites and the biological processes related to CR-Kp infection. The KEGG and GO enrichment analysis showing the top 25 enriched functions is shown in Supplementary Figure S2. Pathway analysis revealed neomycin, kanamycin, and gentamicin biosynthesis as the top canonical pathways (Supplementary Figure S2A). Similarly, the differential metabolites also could be enriched in ammonia recycling, urea cycle, and glutamate metabolism (Supplementary Figure S2B).

4. Discussion

Pneumonia remains a preeminent cause of death and hospitalization worldwide, particularly between teenagers and aging individuals [15, 16]. K. pneumoniae is one of the most generally isolated pathogens in pneumonia, leading to sepsis [17]. Still, K. pneumoniae is a severe threat, and increasing antimicrobial resistance exacerbates this problem [18]. Although diverse K. pneumoniae isolates may differ in their resistome, according to geographic area, cultural community switch, and antibiotic stewardship, this species exhibits an amenable ability to concentrate and rearrange resistances [19]. Future metabolic and translational studies must be needed to decipher specific targets to design targeted prevention and treatment.

This study serves the first use of GC×GC-TOFMS for the analysis of the metabolomics profiling of CR-Kp-infected patients in plasma. We found that 58 metabolites were differentially expressed in CR-Kp-positive infected patients’ plasma but not the negative ones. Focusing on these metabolites, PCA showed good separation between the samples from both groups. Our study showed that patients infected with CR-Kp had significantly altered metabolic profiles of carbohydrates, organic acids, fatty acids, and amino acids. Notably, N-acetyl glucosamine, butanedioic acid, and myoinositol are the most significantly changed metabolites between the two groups. Research shows that N-acetyl glucosamine (GlcNAc) sugar residues within the core LPS in several species of Gram-negative bacteria play a vital role in targeting the DC-SIGN receptor. DC-SIGN is an innate immune receptor, and the interaction of bacterial core LPS and DC-SIGN may represent an ancient interaction between Gram-negative bacteria and host phagocytic cells [20]. Butanedioic acid (succinic acid) is a dicarboxylic acid in the TCA cycle. Moreover, succinic acid is a microbial metabolite produced by Escherichia coli, Pseudomonas aeruginosa, and K. pneumoniae [21]. Study shows that K. pneumoniae utilizes glycerol as the carbon source to produce succinic acid [22]. Blocking the production of succinic acid may be a potential target for inhibiting CR-Kp. Additionally, myoinositol is rarely reported as a newly discovered metabolite in K. pneumoniae infection, which may also be a potential growth inhibitory target. The neomycin, kanamycin, and gentamicin biosynthesis pathways were significantly changed in the CR-Kp-positive group. We infer that it is related to the use of β-lactam/β-lactamase inhibitor combinations.

In conclusion, this study identifies 58 significant CR-Kp-associated molecules in GC×GC-TOFMS. Myoinositol changes significantly in the CR-Kp-positive and CR-Kp-negative groups and can be used as a potential target for treating CR-Kp infection. Future studies are required to better explore those metabolites as a potential therapeutic target.

5. Limitations

Our study has some notable limitations. To our knowledge, our study is the first metabolome study of carbapenem-resistant Klebsiella pneumoniae. However, it cannot be used by the clinicians directly. Further, the infected patient sample size was limited, and further study is warranted to confirm our findings.

Data Availability

Data is available on request. The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding authors.

Conflicts of Interest

The authors report no conflict of interest.

Authors’ Contributions

Zhougui Ling had the idea and launched the study. Zhongwei Wen and Mei Liu had full access to all data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. All authors reviewed the manuscript and approved the version for publication. Zhongwei Wen and Mei Liu contributed equally to this work.

Supplementary Materials

Supplementary Figure S1: Spearman correlation coefficient analysis. The indicates a positive correlation, while a indicates a negative correlation. Supplementary Figure S2: function enrichment analysis. A, KEGG pathway analysis; B, GO pathway enrichment. Supplementary Table 1: carbapenem-resistant Klebsiella pneumoniae infection-associated metabolites. (Supplementary Materials)

References

R.-W. Tsay, L. K. Siu, C.-P. Fung, and F.-Y. Chang, “Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection,” vol. 162, pp. 1021–1027, 2002.
View at: Google Scholar
M. N. Al-Hasan, B. D. Lahr, J. E. Eckel-Passow, and L. M. Baddour, “Epidemiology and outcome of Klebsiella species bloodstream infection: a population-based study,” Mayo Clinic Proceedings, vol. 85, no. 2, pp. 139–144, 2010.
View at: Publisher Site | Google Scholar
E. A. Neuner, J. Y. Yeh, G. S. Hall et al., “Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections,” Diagnostic microbiology and infectious disease, vol. 69, pp. 357–362, 2011.
View at: Google Scholar
A. Leavitt, I. Chmelnitsky, R. Colodner, I. Ofek, Y. Carmeli, and S. Navon-Venezia, “Ertapenem resistance among extended-spectrum-β-lactamase-producing Klebsiella pneumoniae isolates,” Journal of clinical microbiology, vol. 47, pp. 969–974, 2009.
View at: Google Scholar
J.-J. Wu, L.-R. Wang, Y.-F. Liu, H.-M. Chen, and J. J. Yan, “Prevalence and characteristics of ertapenem-resistant Klebsiella pneumoniae isolates in a Taiwanese university hospital,” vol. 17, pp. 259–266, 2011.
View at: Google Scholar
M. Shanthi and U. Sekar, “Extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes,” Journal of the Association of Physicians of India, vol. 58, pp. S41–S44, 2010.
View at: Google Scholar
X. Liu and J. W. Locasale, “Metabolomics: a primer,” vol. 42, pp. 274–284, 2017.
View at: Google Scholar
A.-H. Emwas, R. Roy, R. T. McKay et al., “NMR spectroscopy for metabolomics research,” Metabolites, vol. 9, p. 123, 2019.
View at: Google Scholar
R. Chaleckis, I. Meister, P. Zhang, and C. E. Wheelock, “Wheelock, Challenges, progress and promises of metabolite annotation for LC–MS-based metabolomics,” Current opinion in biotechnology, vol. 55, pp. 44–50, 2019.
View at: Google Scholar
D. J. Beale, F. R. Pinu, K. A. Kouremenos et al., “Review of recent developments in GC–MS approaches to metabolomics-based research,” Metabolomics, vol. 14, pp. 1–31, 2018.
View at: Google Scholar
S. Shoja, M. Ansari, F. Faridi et al., “Identification of carbapenem-resistant Klebsiella pneumoniae with emphasis on New Delhi metallo-beta-lactamase-1 (bla NDM-1) in Bandar Abbas, South of Iran,” Microbial Drug Resistance, vol. 24, pp. 447–454, 2018.
View at: Google Scholar
C. A. Rees, A. Smolinska, and J. E. Hill, “The volatile metabolome of Klebsiella pneumoniae in human blood,” Journal of breath research, vol. 10, article 027101, 2016.
View at: Google Scholar
X. Zheng, K. Zhou, Y. Zhang et al., “Food withdrawal alters the gut microbiota and metabolome in mice,” The FASEB Journal, vol. 32, pp. 4878–4888, 2018.
View at: Google Scholar
R. Wei, J. Wang, M. Su et al., “Missing value imputation approach for mass spectrometry-based metabolomics data,” Scientific reports, vol. 8, pp. 1–10, 2018.
View at: Google Scholar
J. P. Janssens and K. H. Krause, “Pneumonia in the very old,” The Lancet infectious diseases, vol. 4, pp. 112–124, 2004.
View at: Google Scholar
K. McIntosh, “Community-acquired pneumonia in children,” New England Journal of Medicine, vol. 346, pp. 429–437, 2002.
View at: Google Scholar
C. I. Kang, J. H. Song, D. R. Chung et al., “Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia,” Journal of Infection, vol. 62, pp. 26–33, 2011.
View at: Google Scholar
C. J. Norsigian, H. Attia, R. Szubin et al., “Comparative genome-scale metabolic modeling of metallo-beta-lactamase–producing multidrug-resistant Klebsiella pneumoniae clinical isolates,” Frontiers in cellular and infection microbiology, vol. 9, p. 161, 2019.
View at: Google Scholar
S. Navon-Venezia, K. Kondratyeva, and A. Carattoli, “Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance,” FEMS microbiology reviews, vol. 41, pp. 252–275, 2017.
View at: Google Scholar
P. Zhang, S. Snyder, P. Feng et al., “Role of N-acetylglucosamine within core lipopolysaccharide of several species of gram-negative bacteria in targeting the DC-SIGN (CD209),” The Journal of Immunology, vol. 177, pp. 4002–4011, 2006.
View at: Google Scholar
A. Gupta, M. Dwivedi, A. A. Mahdi, C. L. Khetrapal, and M. Bhandari, “Broad identification of bacterial type in urinary tract infection using 1H NMR spectroscopy,” vol. 11, pp. 1844–1854, 2012.
View at: Google Scholar
V. Kumar and S. Park, “Potential and limitations of Klebsiella pneumoniae as a microbial cell factory utilizing glycerol as the carbon source,” Biotechnology advances, vol. 36, pp. 150–167, 2018.
View at: Google Scholar

Copyright

Copyright © 2021 Zhongwei Wen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

523

Downloads

528

Citations